Theorem Clinical Research, a US contract research organisation (CRO), has appointed Brian Bollwage to the position of vice president of global regulatory affairs.
Bollwage was previously director of global regulatory science at Bristol-Myers Squibb and executive director and regulatory counsel of global regulatory intelligence at i3 Research.
He is a food and drug law expert and a graduate of Rutgers Law School. He currently serves as an associate professor of food and drug law at Temple University in Philadelphia.
Theorem Clinical Research appoints vp of global regulatory affairs
Brian Bollwage is a food and drug law expert
You may also like
Manufacturing
Advancing targeted protein degraders: leveraging CMC strategies for rapid IND submission and bioavailability solutions
In the rapidly evolving pharmaceutical landscape, targeted protein degraders (TPDs) represent a significant leap forward. TPDs offer a novel therapeutic modality with the potential to address disease-causing proteins that have traditionally been difficult to target with conventional small molecules